Behavior Risk Factors and Lipid Profiles of Diabetes Mellitus with Hypertension Among Adult Population in Indonesia by Kusumawardani, N. (Nunik) et al.
Vol. 7, No. 2, December 2016 Lipid pro and behavior risk of DM with hypertension 97
Behavior risk factors and lipid profiles of diabetes mellitus with hypertension 
among adult population in Indonesia
Nunik Kusumawardani,1 Suhardi,1 Julianty Pradono,1 Delima,1 Ni Ketut Aryastami,1 Anand Krishnan2
1 National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
2 Centre for Community Medicine All India Institute of Medical Sciences, New Delhi, India
Corresponding address : Nunik Kusumawardani, MScPH, PhD
Email : nunikk@gmail.com
Received: Juli 01, 2016; Revised: October 10, 2016; Accepted: November 21, 2016
Abstrak
Latar belakang: Penyakit Diabetes Mellitus (DM) yang disertai dengan Hipertensi dapat meningkatkan 
risiko terjadinya disabilitas dan kematian premature. Data besaran masalah DM yang disertai Hipertensi 
masih terbatas pada data dari fasilitas kesehatan sementara data berbasis populasi merupakan informasi 
penting untuk memberikan gambaran besaran masalah secara nasional di masyarakat. Studi ini bertujuan 
untuk mendapatkan gambaran besaran masalah DM dengan disertai Hipertensi serta hubungannya dengan 
faktor risiko PTM lainnya berdasarkan data RISKESDAS 2013 yang mencakup 34 Provinsi di Indonesia. 
Metode: Studi Ini merupakan analisis data sekunder dari RISKESDAS 2013 yang mencakup 33 provinsi di Indonesia. 
Data dikumpulkan menggunakan kuesioner terstruktur dan pengukuran tekanan darah dan pemeriksaan darah. 
Jumlah sampel yang dianalisis adalah 35, 931 individu usia 18 tahun ke atas. Pemilihan sampel dengan cara “four 
stages stratified sampling method”. 
Hasil: Hasil analisis menunjukkan bahwa prevalensi DM dengan disertai Hipertensi adalah sebesar 3,0%, 
dengan prevalensi tertinggi sebesar 14% pada laki-laki dan 8% pada perempuan. DM dan hipertensi 
mempunyai hubungan yang bermakna dengan indeks merokok (OR:2,94) pada laki-laki, dengan obesitas 
(OR: 2,35 pada laki-laki dan 2,19 pada perempuan), dan dengan kolesterol darah (OR: 1,86 pada laki-
laki dan 3,45 pada perempuan). 
Kesimpulan: Beberapa faktor risiko seperti indeks masa tubuh, profil lemak, konsumsi buah dan sayuran 
serta merokok dapat dijadikan indikator untuk pencegahan penyakit komplikasi DM dan hipertensi, risiko 
disabilitas dan kematian prematur. (Health Science Journal of Indonesia 2016;7(2):97-106)
Kata Kunci:  diabetes mellitus, hipertensi, faktor risiko perilaku
Abstract
Background: Diabetes mellitus (DM) with hypertension increases risk of disability and premature death. 
Data on DM with hypertension is limited to hospital based data, while population-based data is important 
to provide problem magnitude in the population setting. This study aimed to describe issues magnitude of 
diabetes mellitus with hypertension and relationship with other NCD risk factors in Indonesia based on 
national population based survey. 
Method: This is a data analysis from a cross sectional national health survey (RISKESDAS) in 2013 that 
covered 33 provinces in Indonesia. Data was collected using structured questionnaire and measurement. 
Sample was 35,931 people aged 18+ years. Sampling method used four stages stratified sampling method. 
Results: This study showed prevalence of diabetes mellitus with hypertension was 3.0%, the highest 
prevalence was 14% for male and 8% in female. Diabetes mellitus with hypertension had significant 
relationship to smoking index in male (OR:2.94), obesity in male (OR: 2.35) and female (OR: 2.19) and 
blood cholesterol (OR: 3.45 in female and OR:1.86 in male). 
Conclusion: Health risk monitoring on body mass index, lipid profile, fruits and vegetables consumption, 
and smoking, will be crucial as a secondary prevention among DM and Hypertension case towards 
further complication, and risk of disability and premature death. (Health Science Journal of Indonesia 
2016;7(2):97-106)
Keywords : diabetes mellitus, hypertension, behaviour risk factors
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Recently, diabetes mellitus (DM) and hypertension 
are major public health issues in most countries. In 
Indonesia, results of various National Health Surveys 
(NHS) between 1995 and 2013 showed a three-fold 
increase in prevalence of hypertension among those 
aged 15 years and above. Similarly, the prevalence 
of DM in Indonesian urban population aged 15 
years and above increased from 5.7% in 2007 to 
6.8% in 2013. Even though the prevalence of DM 
was not as high as hypertension, it leaded to greater 
risk of disability, nutrition related diseases and other 
metabolic syndrome as well as risk of its co-morbidity 
such as hypertension and other cardiovascular 
diseases. DM and hypertension are chronic conditions 
that appear to be closely related.1 They share many 
common risk factors such as unhealthy diet, obesity, 
lack of physical activity and smoking.2,3
Abnormal blood glucose is clinically related to 
hypertension with chronic insulin resistance leading 
to increased blood pressure.2,4  Patients with DM are 
twice as likely to have hypertension as compared 
to those without diabetes mellitus.3 It is postulated 
that genetic, environmental and physical factors 
interact with each other and contributes to insulin 
resistance which then leads to hyperglycaemia, 
dyslipidaemia and hyperinsulinemia. These cause 
vascular dysfunction resulting in hypertension in 
the long run.2 In addition, a systematic review have 
shown that hypertension and/or diabetes mellitus is 
more likely lead to signs of cognitive dysfunction, 
widespread structural atrophy, vascular damage 
and functional changes.5  A study in China (2009) 
described that ocular hypertension was significantly 
associated with the presence of diabetes mellitus.6 
On the other hand, a study in England (2000) showed 
that hypertension and antihypertensive therapy may 
lead to risk of type 2 DM, although it is still required 
more supportive evidences.7,8  
The presence of DM and hypertension increases the 
risk of morbidity and mortality significantly. A study in 
Botswana (2007) described that DM with hypertension 
increased the risk of renal failure and cardiovascular 
death.9 Mortality rates among people with hypertension 
and diabetes were 2.5 times higher than those without 
either condition.10 Adverse effects of DM and 
hypertension relates to health-related quality of life.11
Based on the above discussion, it was quite clear 
subjects with both hypertension and diabetes form an 
important group of population who were at increased 
risk of disability and mortality and should be a priority 
for health system to prevent, identify and initiate 
treatment. Studies in Indonesia were not focused on 
this sub-group and very limited information on DM 
with hypertension and its association with behavior 
risk factors and lipid profile. 
This study aimed to describe the epidemiology of 
DM and hypertension in Indonesian population. 
Particularly, it would describes the prevalence of DM 
with hypertension in Indonesia and its association 
with social demographic, behaviour and biochemical 
determinants.  
METHODS 
This study utilized data from the Indonesia NHS 
(National Health Survey) 2013 or in local term it is 
called RISKESDAS. This analysis consisted of 35, 
931 people ( 20,874 female and 15,057 male) aged 18 
years and above. The Indonesia NHS used a four stage 
stratified sampling method. The first strata utilized 
systematic sampling of group of census blocks, the 
second strata used a Proportional to Enrolment Size 
design to identify two census blocks followed by 
systematic sampling of 25 census buildings, and 
finally random sampling was done to choose one 
household within the census buildings. All individuals 
above 18 years were included in the study.
Collected variables included social and demography 
data (sex, education background, occupation, 
residential areas, economic quintile), behaviour health 
risks (smoking, fruits and vegetables consumption), 
physical health risk (blood pressure and body mass 
index), biomedical risk factors (blood glucose, lipid 
profile). Data of behaviour risk factors were collected 
by face to face interview using structured questionnaire. 
Smoking index was calculated using Brinkman Index 
(number of cigarette per day and number of years 
smoking). Body mass index was measured by digital 
body scale and height measurement by aluminium 
height measurement tool. Obesity was defined as 
having BMI >= 25 kg/m2 (WHO, 2004).
Blood pressure was measured by digital tool (Omron 
IA1). The blood pressure measurement was performed 
by trained health workers twice or three times for 
each respondents under the normal condition (sitting 
position after 10 minutes of rest, no smoking, 
coffee/tea consumption, exercise and stress at least 
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30 minutes before measurement). The range time 
between measurements was five minutes and the 
third measurement was done only if the differences 
between first and second measurement was 10 mmHg 
or higher.  Two or three repeated readings were taken 
on the same arm and the mean of the two or three 
measures was used for the analysis.  Hypertension 
was categorized by having systolic blood pressure >= 
140 mmHg or diastolic blood pressure>= 90 mmHg or 
if they were taking medical treatment. Hypertension 
criteria was based on the Seven report of the Joint 
National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure. 
Fasting blood tests for glucose and lipid were 
conducted in local government laboratory clinic. 
The measurement used venous blood with two hours 
postprandial method. Anhydrite Glucose load of 75 
mg in 250 ml water for respondent with no diabetes 
history or 300 calorie liquid food (diabetasol) for 
those who had DM (fasting blood glucose >= 126 
mg/dl) was given to respondents after the fasting 
venous blood was taken. Respondents were not 
allowed to do vigorous physical activity, smoking, 
eating or drinking (except plain water) during the 
two hours after the fasting blood was taken and 
finger capillary glucose blood test was performed 
after the two hours after glucose load. Blood glucose 
was measured by glucometer Accu-Check Performa. 
Diabetes was diagnosed if 2 hours post glucose load 
levels of blood glucose were 200 mg/dl or higher.12  
Fasting lipid profile (cholesterol, HDL, LDL, 
Trygliceride) was measured by obtaining blood 
serum and used automatic device (Roche® COBAS 
6000 c501 Analyzer) with enzymatic process (Jaffé-
picrate). Lipid profile reading was based on National 
Cholesterol Education Program Adult Treatment 
Panel III (NCEP ATP III) which used cut off for 
abnormal blood cholesterol level was >= 200 mg/dl. 
Cut off for other lipid profile were < 40 for HDL, >= 
130 for LDL and >= 150 for Triglyceride. 
All the measurement tools had been validated and 
calibrated prior to the data collection. The validation 
was conducted in term of sensitivity and specificity. 
The survey was conducted by National Institute of 
Health Research and Development and approved by 
a national ethical committee in Indonesia. Written 
consent was taken from respondents.
Point estimates of the prevalence by sex had been 
calculated and 95% confidence intervals were 
used based on cluster sample analysis using SPSS 
package. A cross tabulation was used to describe 
the behaviour risk factors, anthropometry, biological 
and biochemical risk factors (fruits and vegetable 
consumption, smoking, obesity, hyperglycaemia, 
hypertension, hyperlipidaemia). Multivariate analysis 
was done to calculate Odds-ratio (with 95% CI) for 
the determinants with diabetes with hypertension as 
the outcome variable. 
RESULTS  
Results from this study describes relationship between 
behaviour risk factors (smoking; fruits and vegetable 
consumption), physical risk (body mass index), lipid 
profile and Diabetes (DM) with hypertension as well 
as DM and hypertension in single condition. From 
table 1, national prevalence of hypertension in the 
population was 25.8% (95% CI 25.6-26.0) and of DM 
was 6% (95% CI 5.6-6.4) among population above 
18 years in Indonesia. The prevalence of DM with 
hypertension was 3.0% (95%CI 2.7-3.3) in which 
the prevalence is significantly higher among female 
(3.7%, 95%CI 3.4-4.1) than males (2.0%, 95% CI 
1.7-2.3). The prevalence of DM and hypertension 
increased with age. Female had significantly higher 
prevalence of diabetes with hypertension than 
male. There were no major rural/urban or economic 
differentials in its prevalence. 
Overall, the distribution of the prevalence of DM 
with hypertension across the 33 districts was different 
between male and female, whereas male had higher 
prevalence than female in general. The highest 
prevalence reached 14.3% in male (in Province of 
Sulawesi Tenggara) and was 8.3% in female (in 
Province of Bangka Belitung) and the lowest was in 
Province of Papua Barat (both male and female)
Among the male population, relationship of 
behaviour related determinants (body mass index 
and smoking index) shows significant differences 
(Table 2). Those with BMI >= 25 kg/m2 (OR= 2.354) 
and smoking >= 200 cigarette sticks during lifetime 
(OR = 2.94) were related to higher risk of DM with 
hypertension (Table 2 ).  The prevalence of DM with 
hypertension was 3.6% (CI 2.9%-4.5%) in BMI >= 
25 kg/m2 compare to lower BMI (1.6%,CI 1.3-1.9) 
Similarly, the prevalence of DM with hypertension 
was higher among those who were heavy smokers 
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(Brinkman Index >= 200 stick in life years) than 
light smokers, which was 2.5%, CI 2.0%-3.2% vs 
0.9%,CI 0.6%-1.2% in male. Fruit and Vegetable 
intake was associated with presence of DM with 
hypertension and DM alone, but no association 
with the hypertension. In fact, the prevalence of 
hypertension was most likely higher among those 
with higher consumption of fruits and vegetable. It 
can be assumed that adequate fruit and vegetable may 
not necessary lead to lower blood pressure without 
controlling other high natrium source of food. 
This study shows that prevalence of DM with 
hypertension in male was significantly higher 
among those who had blood cholesterol >=200 
mgdL in comparison to lower blood cholesterol 
(3.0% vs 1.6%; OR=1.86) and among those who 
had LDL >=130 in comparison to lower LDL (2.6% 
vs. 1.6%; OR=1.61). Other lipid profile (HDL and 
triglyceride) did not showed significant contribution 
to higher DM with hypertension prevalence among 
male population (Table 2). The relationship pattern 
is more likely similar with the single condition of 
hypertension and DM. Prevalence of DM with 
hypertension was higher among those with higher 
triglyceride, although the relationship was weak 
(2.4% vs. 1.8%; OR=1.29).
Table 1. Prevalence of Diabetes Mellitus with Hypertension by population characteristics, RISKESDAS 2013
Population characteristic n DM with 
hypertension
(95% CI)
N DM
(95% CI)
n Hypertension
(95% CI)
Age group 18-24 years 3,586 0.01%
(0.01% - 0.2%)
3,604 1.0% 
(0.7%-1.5%)
91,903 8.7%
 (8.3%-9.0%)
25-34 years 6,762 0.7% 
(0.5%-1.0%)
6,781 2.3% 
(1.9%-2.8%)
141,991 14.7% 
(14.3%-15.0%)
35-44 years 9,014 2.2%
(1.9% - 2.6%)
9,042 5.3% 
(4.7%- 6.0%)
159,821 24.8% 
(24.4%-25.2%)
45-54 years 7,839 4.3% 
(3.8% - 4.9%)
7,857 8.9% 
(8.1 – 9.8%)
130,295 35.6% 
(35.1%-36.0%)
55-64 years 5,263 7.0% 
(6.1% - 8.1%)
5,280 12.0% 
(10.8%-13.3%)
81,376 45.9% 
(45.4%-46.5%)
65-74 years 2,533 8.8% 
(7.4% - 10.3%)
2,542 12.3% 
(10.6%-14.1%)
38,976 57.6% 
(56.8%-58.3%)
75+ years 934 7.9% 
(6.0% - 10.2%)
939 12.5% 
(10.0%-15.6%)
17,005 63.8% 
(62.8%-64.9%)
Sex Male 15,057 2.0%
 (1.7% - 2.3%)
15,104 4.3%
(3.9%-4.8%)
316,617 22.8% 
(22.5%-23.0%)
Female 20,874 3.7% 
(3.4%-4.1%)
20,941 7.2%
(6.7% - 7.8%)
344,750 28.8% 
(28.5%-29.1%)
Residential areas Urban 16,253 2.9%
 (2.6%- 3.3%)
16,322 5.5% 
(5.0% - 6.1%)
305,156 26.1%
 (25.7%-26.6%)
Rural 19,678 3.1% 
(2.7% - 3.5%)
19,723 6.5% 
(5.8% - 7.2%)
356,211 25.5%
 (25.2%-25.8%)
Economic status Quintile 1 5,784 2.6% 
2.1% - 3.1%)
5,795 5.7% 
(4.9%- 6.7%)
121,635 25.5 % 
(25.0%-26.0%)
Quintile 2 7,605 3.0% 
(2.5% - 3.5%)
7,621 5.5% 
(4.8%-6.4%)
127,956 27.2% 
(26.8%-27.6%)
Quintile  3 8,424 2.8% 
(2.3%- 3.2%)
8,453 5.7% 
(5.1%-6.4%)
134,570 25.9% 
(25.5% - 26.4%)
Quintile  4 8,022 3.3% 
(2.8% - 3.8%)
  8,053 6.5% 
(5.7%-7.3%)
138,624 25.1%
 (24.7% -25.6%)
Quintile 5 6,096 3.3 % 
(2.8%-3.9%)
6,123 6.5% 
(5.6% - 7.5%)
138,582 25.4% 
24.9% - 25.9%)
Total 35,931 3.0% (2.7% - 3.3%)
36,045 6.0% 
5.6% - 6.4%)
661,367 25.8% 
(25.6%-26.0%)
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Meanwhile among the female population, the DM 
with hypertension prevalence showed different 
pattern. No significant different between female 
who smoke less and heavy smokers, neither between 
low and adequate fruit and vegetable consumption 
(Table 3). Prevalence of DM with hypertension was 
5.7% (CI 5.0%-6.4%) vs 2.7% (CI 2.3%-3.0%) in 
female who had obesity and 4.1%, CI:1.6%-10.3% 
vs 1.6%, CI: 1.9%-8.7% in female who had smoking 
index >=200. The prevalence was higher but not 
significant among female who has higher smoking 
index and fruits and vegetable consumption. 
However, the prevalence was significantly higher 
among female who were heavy smokers in single 
condition of hypertension (OR= 1.48) or DM  (OR= 
1.24) compare to female with lower smoking index. 
Relationship between obesity (BMI>= 25 kg/m2) 
and DM with hypertension, hypertension and DM 
was strong (OR= 2.19 for DM with hypertension, 
2.40 for hypertension, 1.56 for DM). The prevalence 
of DM with hypertension was significantly higher 
among female with obesity, as well as the prevalence 
of hypertension and DM in single condition. 
The relationship between lipid profile and DM with 
hypertension was most likely strong among female, 
whereas the prevalence was higher among female 
who had higher lipid profile (6.8% vs 2.1% for blood 
cholesterol; 4.9% vs 3.6% for HDL; 6.3% vs 2.0% 
for LDL and 7.6% vs 2.8% for triglyceride). Similar 
pattern was shown for the relationship between 
lipid profile and hypertension. The prevalence of 
hypertension among females was significantly 
higher in female with high blood cholesterol, LDL, 
and triglyceride. Specifically for DM, the DM 
prevalence was significantly higher among female 
who have high in all the lipid profile (Cholesterol, 
HDL, LDL and triglyceride). 
DISCUSSION
The prevalence of DM with hypertension in 
Indonesia tended to increase by age and among 
female. Most of NCD is most likely having linear 
positive relationship with aging due to metabolic 
pathway or biologic change during aging, which 
can be positively or negatively modified by life style 
risk factors such as diet, smoking, physical activity 
and alcohol consumption. These risk factors have 
been known to be related to socio demographic 
condition such as income and education background 
as well as cultural aspects. In other Asian countries, 
such as in Thailand, the prevalence of DM with 
hypertension in 2008 was higher (8.1% in males and 
10.3% in females)13 than in Indonesia during 2013. 
The prevalence in Indonesia was not much different 
between urban and rural population. This pattern 
was also seen in DM or hypertension alone. 
More than half of DM cases in Indonesia were also 
having hypertension (50.8% in male and 56.5% in 
female). A study in Bostwana in 2007 showed that 
about 67% of DM patients suffered hypertension.9 
The Study was done in 401 subjects and used a 
cross sectional design. The subject of the study was 
all of the DM patients who follow diabetic care in 
Garborone City Council fourteen clinics.9  
Female tended to have greater prevalence of DM with 
hypertension and also stronger relationship with behavior 
risk factors compared to male. These could be related 
to the general lifestyle differences between the genders 
which may be compounded by other special metabolic 
susceptibilities, like due to hormonal influences. 
There were major geographical differences in 
the prevalence of DM with hypertension. It can 
be assumed that these differences were related to 
cultural factors which influence life style such as 
dietary habit. Indonesia has more than hundred 
of different ethnicities and food cultures across 
provinces. Sulawesi Tenggara is one of the provinces 
with good resources of seafood including salted fish 
which is commonly consumed in daily basis. 
Similar pattern of relationship has been reported 
from other countries such an in Africa and Taiwan.9 
The study in Bostwana Africa also showed that 
overweight and obesity and hypertriglyceridemia 
have significant relationship with DM with 
hypertension.9 A cross sectional study in India, 
showed a correlation between hypertension and 
hyperglycemia among young adult aged 17 to 
19 years.14 Different country may have different 
discrepancy of the problem magnitude of DM with 
hypertension. In Indonesia, this analysis have shown 
prevalence discrepancy across 33 provinces and the 
difference is as high as more than 10 times between 
the lowest and the highest. 
This study highlighted three main areas that may 
contribute to policy implications: 1) prevention and 
controlling of co-morbidity among diabetes patients; 
2) gender sensitive prevention and control strategies; 
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3) biological and biochemical risk factors screening 
among diabetes cases. 
Prevention and controlling of co-morbidity of DM
This study showed that hypertension is one of the 
common co-morbidity of DM, as about fifty percent 
of diabetes cases had hypertension. Several studies 
also found that DM with hypertension lead to 
greater risk of cardiovascular death.10 In this case, a 
secondary prevention among DM case is crucial to 
avoid disability, case fatality and premature death. A 
longitudinal study done by Hassing L B et all in 2004 
showed that DM with hypertension co-morbid lead to 
greater risk of having cognitive decline.15 A study in 
Turkey also found that combination of hypertension 
and obesity and DM lead to lower quality of life.16 
The prevention may need to focus on medical 
treatment compliant and healthy life style practice 
in both facility and community based approaches. In 
term of health facility-based approaches several key 
interventions include adequate access to good quality 
health services in term of drug availability, devices, 
treatment and health education and counseling. It 
is also important to have adequate communication 
between patient and physician. A study among 
diabetes patients in DeBakey VA Medical Centre in 
Houston indicated that sufficient communication 
of patient-clinician had significant association with 
hypertension control.17 While in the community-
based approaches, the intervention is directed towards 
public awareness and conducive living environments 
that allow community to practice healthy lifestyle. 
Gender sensitive prevention and control strategies
In Indonesia context, prevention and control strategies 
non-communicable disease, in some extent, applied 
generic or common strategies for both gender except 
for the maternal related diseases. It is obvious that 
males and females have their own unique pattern and 
magnitude of NCD, including DM and hypertension 
and NCD risk factors association that lead to different 
needs and priority areas to be addressed. Females 
tend to have more issues on obesity, smoking and 
hyperlipidemia as risk factors while males have 
more problem on smoking and hyperlipidemia. 
Smoking seems to affecting towards higher risk 
of cardiovascular diseases and other diabetes co-
morbidity. Although prevalence of smoking is much 
more lower among females than males aged 10 
years and above in Indonesia (1.9% vs 56.7%)18, the 
health impact is similarly crucial for both males and 
females. The smoking index (years and number of 
cigarettes) are higher in males than females (243 in 
males and 173.4 in females).18 Meanwhile, obesity 
tends to contribute more serious health impact on 
females. Body mass index control and monitoring 
can be more strengthened among females, which 
lead to more intervention focus on healthy diet and 
sufficient physical activity. Hyperlipidaemia is one 
of the health risk issues that correlate with diabetes 
co-morbidity for both males and females.
Physical and biochemical risk factors screening 
among diabetes cases
This study shows that biological risk factors such 
as body mass index and lipid profile are crucial to 
be monitored and controlled among the diabetes 
cases to prevent co-morbidity that may lead to 
premature death and diseases related disability. 
Maintaining normal body mass index is very 
challenging, particularly among productive age 
group. It is intervened by childbearing period among 
females and physical inactivity among working 
aged males, as well as aging effect. Particularly 
among those who have DM required strategy that 
enable them maintaining normal body mass index, 
blood pressure and in preventing central obesity. 
Similarly, monitoring and controlling lipid profile 
such as cholesterol, LDL, triglyceride and HDL, 
among DM case refers to applying healthy life style. 
In this case, routine monitoring and controlling of 
blood pressure, body weight and lipid profile should 
be included in the DM case manageable standard 
to avoid more complicated treatment which lead 
to more costly health expenditure. Evidences from 
other country, such in Canada also showed that the 
Canadian Hypertension Education Program has 
recommended to include hypertension monitoring 
among DM patients.19 It is also known that DM, 
hypertension and kidney disease are interrelated in 
which they lead to greater cardiovascular risk.20,21 A 
randomized trial among type 2 diabetes showed that 
controlling blood pressure to 135/80 mmHg provide 
intense benefits to prevent adverse outcome of type 
2 diabetes patients.22 Reviews of benefits and risk of 
monitoring blood pressure among diabetes cases in 
Canada highlighted that treatment of hypertension 
in people with diabetes is highly effective strategy 
to reduce the risk of cardiovascular disease and 
diabetes complication.23
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Further studies are required to address more 
specific issues on DM with hypertension in specific 
geographical setting such an in province with the 
highest proportion of DM with hypertension in 
Sulawesi Tenggara. More specific intervention 
programs should consider areas or population 
with high, moderate and low proportion of DM 
with hypertension, hypertension as well as DM. 
The interventions should also put into account 
specific approached on different age groups such as 
adolescents, adult and elderly.
In conclusion, DM with hypertension has significant 
relationship to certain health risks (behavior, physical 
and biomedical) among Indonesian adult aged 18 
years and above. Routine monitoring and controlling 
of body weight, blood pressure and lipid profile are 
crucial to prevent DM comorbidity and case fatality 
among DM cases. This study also suggested reducing 
and controlling the risk factors (quit smoking and 
healthy diet) to prevent co-morbidity of hypertension 
and diabetes mellitus. 
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